index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

Chargement de la page

Open Access

67 %

Mots clés

Clinical trials Molecular docking Animals Muscle development Immunoglobulin Fc Fragments/pharmacology Allele‐specific silencing therapy Humans Myotendinous junction Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Génomique Cell Line Gene Expression Regulation/drug effects Duchenne muscular dystrophy DMD Gene modifiers Muscle Biology Genomic Becker muscular dystrophy DHPR α1S Invivo Muscles/physiopathology Long noncoding RNA DMO Animal/physiopathology Cachexia Inhibitors Becker muscular dystrophy BMD Diseases L-Type Cultured Homeostasis Inbred mdx Gene expression Cardiomyopathy Drp1 Becker BMD muscular dystrophy CTNNB1 CD38 NNOS MiARN Epigenetics Centronuclear myopathy Dystrophin-EGFP Myogenesis DMD Duchenne muscular dystrophy BMD LncARN Knockout Muscle LKB1 Dystrophy Male Human Umbilical Vein Endothelial Cells Hear Skeletal muscle Muscle Strength Dystrophie Musculaire de Duchenne DMD Dynamin 2 Dystrophie Musculaire de Becker BMD Activin Receptors CaVβs MES CaV subunits Cardiomyopathie Multi resolution modeling Cells Mitochondrial fission Modificateurs de gènes Hepatocellular carcinoma Exon skipping Antisense oligonucleotides Muscular Atrophy Ex-vivo Dystrophie musculaire de Becker Mdx mouse Molecular Sequence Data Dystrophin Metabolism Autophagy Duchenne DMD dystrophy Multi exon skipping Cell homeostasis Liver Long QT Muscular dystrophy LncRNA NAD+ Multiresolution modeling Inbred C57BL Delivery Cell Biology Morphogenesis Dystrophine Base Sequence Energy Metabolism/drug effects Calcium Channels Calcium Muscular Dystrophy Dystrophin central domain Mice